Literature DB >> 22922090

Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury.

Kenneth I Strauss1, Artiom Gruzdev, Darryl C Zeldin.   

Abstract

After traumatic brain injury (TBI), arachidonic acid (ArA) is released from damaged cell membranes and metabolized to many bioactive eicosanoids, including several epoxyeicosatrienoic acids (EETs). Soluble epoxide hydrolase (Ephx2, sEH) appears to be the predominant pathway for EET metabolism to less active dihydroxyeicosatrienoates (DHETs). Prior studies indicate that brain levels of EETs increase transiently after TBI and EETs have antiinflammatory and neuroprotective activities which may benefit the injured brain. If the net effect of increased EET levels in the injured brain is beneficial to recovery, then Ephx2 gene disruption would be expected to enhance elevated EET levels and improve recovery in the injured brain. Thus, Ephx2-KO (Ephx2(-/-) bred onto pure C57Bl/6 background) mice were compared to wild-type controls in a unilateral controlled cortical impact model of TBI. Before injury, animals behaved comparably in open field activity and neurologic reflexes. Interestingly, the Ephx2-KO mice showed improved motor coordination on a beam walk task, yet showed indications of defective learning in a test of working spatial memory. After surgery, brain-injured Ephx2-KO mice again had less of a deficit in the beam walk than wild-type, and the difference in latency (post-pre) showed a trend of protection for Ephx2-KO mice after TBI. Brain-injured mice showed no genotype differences in working memory. Surprisingly, sham-operated Ephx2-KO mice exhibited an injured phenotype for working memory, compared to sham-operated wild-type mice. Brain eicosanoid levels were measured using liquid chromatography with tandem mass spectrometry. Of the 20 eicosanoids evaluated, only 8,9-EET was elevated in the Ephx2-KO cerebral cortex (37 d post-surgery, in both sham and injured). Tissue DHET levels were below the limit of quantification. These results reflect a significant contribution of sEH deficiency in coordination of ambulatory movements and working spatial memory in the mouse. Further investigation of differential sEH expression and EET levels at earlier time points and across other brain regions may shed light on these behavioral differences.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922090      PMCID: PMC3932494          DOI: 10.1016/j.prostaglandins.2012.07.005

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  36 in total

1.  Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

Authors:  K Node; Y Huo; X Ruan; B Yang; M Spiecker; K Ley; D C Zeldin; J K Liao
Journal:  Science       Date:  1999-08-20       Impact factor: 47.728

Review 2.  Opioids, NSAIDs and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism.

Authors:  M J Christie; C W Vaughan; S L Ingram
Journal:  Inflamm Res       Date:  1999-01       Impact factor: 4.575

3.  Adult neurological function following neonatal hypoxia-ischemia in a mouse model of the term neonate: water maze performance is dependent on separable cognitive and motor components.

Authors:  John J McAuliffe; Lili Miles; Charles V Vorhees
Journal:  Brain Res       Date:  2006-09-25       Impact factor: 3.252

4.  Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function.

Authors:  John M Seubert; Christopher J Sinal; Joan Graves; Laura M DeGraff; J Alyce Bradbury; Craig R Lee; Kerry Goralski; Michelle A Carey; Ayala Luria; John W Newman; Bruce D Hammock; John R Falck; Holly Roberts; Howard A Rockman; Elizabeth Murphy; Darryl C Zeldin
Journal:  Circ Res       Date:  2006-07-20       Impact factor: 17.367

5.  Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors.

Authors:  Kara R Schmelzer; Bora Inceoglu; Lukas Kubala; In-Hae Kim; Steven L Jinks; Jason P Eiserich; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-01       Impact factor: 11.205

6.  Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.

Authors:  Ayala Luria; Steven M Weldon; Alisa K Kabcenell; Richard H Ingraham; Damian Matera; Huiping Jiang; Rajan Gill; Christophe Morisseau; John W Newman; Bruce D Hammock
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

7.  A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in rat brain tissue.

Authors:  Hongfei Yue; Susan A Jansen; Kenneth I Strauss; Michael R Borenstein; Mary F Barbe; Luella J Rossi; Elise Murphy
Journal:  J Pharm Biomed Anal       Date:  2006-11-27       Impact factor: 3.935

Review 8.  Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).

Authors:  Bora Inceoglu; Kara R Schmelzer; Christophe Morisseau; Steve L Jinks; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-07-05       Impact factor: 3.072

9.  A simple, efficient tool for assessment of mice after unilateral cortex injury.

Authors:  Shirley B Shelton; David B Pettigrew; Alison D Hermann; Weidong Zhou; Patrick M Sullivan; Keith A Crutcher; Kenneth I Strauss
Journal:  J Neurosci Methods       Date:  2007-11-19       Impact factor: 2.390

10.  Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.

Authors:  Ines P Koerner; Rachel Jacks; Andrea E DeBarber; Dennis Koop; Peizhong Mao; David F Grant; Nabil J Alkayed
Journal:  J Neurosci       Date:  2007-04-25       Impact factor: 6.167

View more
  11 in total

1.  Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7.

Authors:  Naoki Matsumoto; Eriko Suzuki; Makoto Ishikawa; Takumi Shirafuji; Keiji Hasumi
Journal:  J Biol Chem       Date:  2014-10-31       Impact factor: 5.157

2.  Fatty acid chemical mediator provides insights into the pathology and treatment of Parkinson's disease.

Authors:  Cesar V Borlongan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-30       Impact factor: 11.205

Review 3.  Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Authors:  Sydney Zarriello; Julian P Tuazon; Sydney Corey; Samantha Schimmel; Mira Rajani; Anna Gorsky; Diego Incontri; Bruce D Hammock; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2018-11-14       Impact factor: 11.685

Review 4.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

Review 5.  Traumatic brain injury using mouse models.

Authors:  Yi Ping Zhang; Jun Cai; Lisa B E Shields; Naikui Liu; Xiao-Ming Xu; Christopher B Shields
Journal:  Transl Stroke Res       Date:  2014-02-05       Impact factor: 6.829

6.  Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders.

Authors:  Navya Lakkappa; Praveen T Krishnamurthy; Bruce D Hammock; D Velmurugan; M M Srinivas Bharath
Journal:  Med Hypotheses       Date:  2016-06-05       Impact factor: 1.538

7.  P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.

Authors:  Xuehong Liu; Catherine M Davis; Nabil J Alkayed
Journal:  Antioxid Redox Signal       Date:  2017-04-20       Impact factor: 8.401

Review 8.  Cytochrome P450 eicosanoids in cerebrovascular function and disease.

Authors:  Catherine M Davis; Xuehong Liu; Nabil J Alkayed
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

9.  Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.

Authors:  Matthew Birnie; Ryan Morrison; Ramatoulie Camara; Kenneth I Strauss
Journal:  BMC Genomics       Date:  2013-05-04       Impact factor: 3.969

Review 10.  The Controlled Cortical Impact Model: Applications, Considerations for Researchers, and Future Directions.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Front Neurol       Date:  2016-08-17       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.